Skip to main content
David Tuveson, MD, Oncology, Philadelphia, PA

David A Tuveson MD


Physician

Join to View Full Profile
  • 3400 Spruce St15 Penn TowerPhiladelphia, PA 19104

  • Phone+1 215-662-3914

Are you Dr. Tuveson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. David Tuveson, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and New York.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1994

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2026
  • PA State Medical License
    PA State Medical License 2003 - 2014

Publications & Presentations

PubMed

Authored Content

  • Successful Creation of Pancreatic Cancer Organoids by Means of EUS-Guided Fine-NeedleJanuary 2018

Press Mentions

  • Targeting FGFR2 May Prevent or Delay Some KRAS-Mutated Pancreatic Cancers
    Targeting FGFR2 May Prevent or Delay Some KRAS-Mutated Pancreatic CancersApril 2nd, 2025
  • AACR Patient Advocate Forum: Patient-Centric Cancer Clinical Trial Design
    AACR Patient Advocate Forum: Patient-Centric Cancer Clinical Trial DesignFebruary 6th, 2025
  • How Pancreatic Cancer Can Be Accelerated by a Splicing-Regulator Protein
    How Pancreatic Cancer Can Be Accelerated by a Splicing-Regulator ProteinApril 27th, 2023
  • Join now to see all

Grant Support

  • Fibroblast Heterogeneity in Pancreatic CancerCOLD SPRING HARBOR LABORATORY2021–2026
  • CSHL Cancer Center Support GrantCOLD SPRING HARBOR LABORATORY1997–2026